首页> 美国卫生研究院文献>Molecules >Tissue Distribution and Anti-Lung Cancer Effect of 10-Hydroxycamptothecin Combined with Platycodonis Radix and Glycyrrhizae Radix ET Rhizoma
【2h】

Tissue Distribution and Anti-Lung Cancer Effect of 10-Hydroxycamptothecin Combined with Platycodonis Radix and Glycyrrhizae Radix ET Rhizoma

机译:10-羟基喜树碱联合桔梗和甘草ET根茎的组织分布及抗肺癌作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

10-Hydroxycamptothecin (HCPT) is a broad-spectrum chemotherapeutic drug, although its side effects and multidrug resistance (MDR) limit its clinical application. A range of drug delivery systems have been utilized to overcome its shortcomings and maintain its therapeutic efficacy, however the use of the transport effect of traditional Chinese medicines (TCMs) to improve the distribution of chemotherapeutic drugs has not been widely reported. Platycodonis Radix (JG) and Glycyrrhizae Radix ET Rhizoma (GC) are common TCMs in clinics and are often combined as drug pairs to act as “transport agents”. In the present study, the effect of JG and GC (JGGC) on the distribution of HCPT in tissues and its antitumor efficacy after being combined as a therapy were investigated, for which ultrahigh-performance liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS) was used. Furthermore, the effect on the protein expression of multidrug resistance proteins (P-gp and LRP), and the immunomodulatory and synergistic antiapoptotic effect on Lewis lung cancer-bearing C57BL/6J mice were also evaluated. The results demonstrate that JGGC significantly increased the area under the concentration time curve (AUC) and mean residence time (MRT) and reduced the clearance rate (CL) of HCPT. In addition, the combined use of JGGC decreased the levels of LRP, P-gp and Bcl-2/Bax when treated with HCPT. JGGC also significantly elevated the levels of RBCs, PLTs, HGB, IL-2, and IFN-γ, and decreased IL-10 levels. In summary, an increased concentration of HCPT in tissues was observed when it was combined with JGGC through inhibition of efflux protein, with a synergistic enhancement of the anticancer effect observed through promotion of apoptosis and immunity due to a reversion of the Th1/Th2 shift. Our findings provide a reference for the feasibility of combining JGGC with chemotherapy drugs in clinical applications.
机译:10-羟基喜树碱(HCPT)是一种广谱化疗药物,尽管它的副作用和多药耐药性(MDR)限制了其临床应用。已经利用多种药物递送系统来克服其缺点并维持其治疗功效,但是尚未广泛报道使用中药(TCM)的转运作用来改善化学治疗药物的分布。 Platycodonis Radix(JG)和Glycyrrhizae Radix ET Rhizoma(GC)是临床上常见的中药,通常作为药物对组合以充当“转运剂”。在本研究中,研究了JG和GC(JGGC)对HCPT在组织中的分布及其联合治疗后的抗肿瘤功效的影响,为此,采用超高效液相色谱-串联质谱(UHPLC-MS / MS)。此外,还评估了对多药耐药蛋白(P-gp和LRP)的蛋白表达的影响,以及对Lewis肺癌的C57BL / 6J小鼠的免疫调节和协同抗凋亡作用。结果表明,JGGC显着增加了浓度时间曲线(AUC)和平均停留时间(MRT)下的面积,并降低了HCPT的清除率(CL)。此外,联合使用JGGC可以降低HCPT治疗时LRP,P-gp和Bcl-2 / Bax的水平。 JGGC还显着提高了RBC,PLT,HGB,IL-2和IFN-γ的水平,并降低了IL-10的水平。总而言之,当HCPT与JGGC通过抑制外排蛋白结合时,在组织中的HCPT浓度增加,并且由于Th1 / Th2移位的逆转,通过促进细胞凋亡和免疫力,协同增强了抗癌作用。我们的发现为在临床应用中将JGGC与化学治疗药物联合使用的可行性提供了参考。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号